ScholarIQanswers from OpenAlex
Hebrew University of Jerusalem
InstitutionResearch output, impact & collaborations
Hebrew University of Jerusalem is a institution indexed in ScholarIQ from OpenAlex.
What is known about Hebrew University of Jerusalem?
ScholarIQrecord summary
Hebrew University of Jerusalem is a research organisation in Jerusalem, IL. OpenAlex records 149,777 works and 11,329,901 citations for it. 23,508 researchers list it as their most recent affiliation.
How many works does Hebrew University of Jerusalem have?
ScholarIQindexed works
Hebrew University of Jerusalem has 149,777 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hebrew University of Jerusalem have?
ScholarIQcitation count
Hebrew University of Jerusalem has 11,329,901 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Hebrew University of Jerusalem?
ScholarIQresearcher count
Hebrew University of Jerusalem has 23,508 researchers in the ScholarIQ index.
What is the average h-index at Hebrew University of Jerusalem?
ScholarIQavg h-index
Hebrew University of Jerusalem has an average h-index of 66.9 in OpenAlex.
What is the ROR of Hebrew University of Jerusalem?
ScholarIQror
The ROR for Hebrew University of Jerusalem is on the source record.
What is the OpenAlex record for Hebrew University of Jerusalem?
ScholarIQopenalex
The OpenAlex for Hebrew University of Jerusalem is on the source record.
Who are the most-cited researchers behind Hebrew University of Jerusalem?
ScholarIQtop researchers by citations
What are the most-cited papers on Hebrew University of Jerusalem?
ScholarIQmost cited works
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Melanie A. Leiby, Gregory M. Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R. Brahmer
Surviving Sepsis Campaign
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R.P. Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Dómine, Philip R. Clingan, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Belén Rubio‐Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E. Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M. Catherine Pietanza, Marina Chiara Garassino
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin, Gulisa Turashvili, Oscar M. Rueda, Mark Dunning, Doug Speed, Andy G. Lynch, Shamith Samarajiwa, Yinyin Yuan, Stefan Gräf, Gavin Ha, Gholamreza Haffari, Ali Bashashati, Roslin Russell, Steven McKinney, Anita Langerød, Andrew R. Green, Elena Provenzano, Gordon Wishart, Sarah E. Pinder, Peter H. Watson, Florian Markowetz, Leigh C. Murphy, Ian O. Ellis, Arnie Purushotham, Anne‐Lise Børresen‐Dale, James D. Brenton, Simon Tavaré, Carlos Caldas, Samuel Aparício
How much of the research on Hebrew University of Jerusalem is open access?
ScholarIQopen access share
67%OPEN ACCESS